Treace Medical Concepts, Inc. (TMCI) Misses Q2 EPS by 2c

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q2 EPS of ($0.23), $0.02 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $30 million versus the consensus estimate of $28.63 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• ASML Holdings (ASML) Tops Q2 EPS by 59c; offers guidance
• Phoenix Education Partners, Inc. (PXED) Misses Q3 EPS by 14c; Offers Outlook
• Macquarie cuts India oil and gas earnings forecasts on losses